1 terminated. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Terminated 1 |
Follow Neoplasms, Second Primary: new trials by email Literature Review of Neoplasms, Second Primary trials Research Report on Neoplasms, Second Primary
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety Study of High Dose Temozolomide to Treat Relapsed/Refractory Central Nervous System (CNS) Malignancy Temozolomide - Central Nervous System Neoplasms, Neoplasm Metastasis | Phase 1 | Terminated | Tufts Medical Center | 2 | 2004-04-01 | 2012-04-27 |
Breast Neoplasms (1) · Central Nervous System Neoplasms (1) · Lung Neoplasms (1) · Melanoma (1) · Neoplasm Metastasis (1)
Breast Diseases (1) · Lung Diseases (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms by Site (1) · Neoplasms, Germ Cell and Embryonal (1) · Neoplasms, Nerve Tissue (1) · Neoplastic Processes (1) · Nervous System Diseases (1) · Nervous System Neoplasms (1) · Neuroectodermal Tumors (1) · Neuroendocrine Tumors (1) · Nevi and Melanomas (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Temozolomide (1)
United States (1)